Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05835050
What this trial is testing

Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital

Who this might be right for
Immune Thrombocytopenic Purpura
Sohag University 50
Not applicableStudy completedNCT01510873
What this trial is testing

Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Gruppo Italiano Malattie EMatologiche dell'Adulto 424
Testing effectiveness (Phase 2)Study completedNCT00392951
What this trial is testing

Sirolimus for Autoimmune Disease of Blood Cells

Who this might be right for
Autoimmune PancytopeniaAutoimmune Lymphoproliferative Syndrome (ALPS)Evans Syndrome+6 more
Children's Hospital of Philadelphia 30
Not applicableStudy completedNCT02298075
What this trial is testing

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 148
Post-approval studies (Phase 4)Ended earlyNCT02512601
What this trial is testing

Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide

Who this might be right for
Post-thrombotic Syndrome
Bama GeVe, S.L.U. 13
Not applicableUnknownNCT06093529
What this trial is testing

Immune Markers in Pediatric ITP on Second Line Therapy

Who this might be right for
ITP - Immune Thrombocytopenia
Assiut University 42
Large-scale testing (Phase 3)Study completedNCT04687072
What this trial is testing

Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 207
Very early researchStudy completedNCT05551624
What this trial is testing

Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

Who this might be right for
Primary Immune Thrombocytopenia
Hospital Civil de Guadalajara 15
Not applicableEnded earlyNCT00901160
What this trial is testing

Thromboelastography (TEG®) and Platelet Function in Patients on Anti-platelet Agents

Who this might be right for
Blood Clotting
McMaster University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05885555
What this trial is testing

Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 41
Large-scale testing (Phase 3)UnknownNCT03177629
What this trial is testing

H. Pylori Eradication for Moderate ITP

Who this might be right for
Immune Thrombocytopenic PurpuraHelicobacter PyloriImmune Thrombocytopenia
Seoul National University Hospital 54
Testing effectiveness (Phase 2)UnknownNCT06658834
What this trial is testing

Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 129
Large-scale testing (Phase 3)UnknownNCT02877212
What this trial is testing

Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75
Large-scale testing (Phase 3)Study completedNCT05422365
What this trial is testing

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Biopharma Plasma LLC 32
Testing effectiveness (Phase 2)Study completedNCT00844428
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 5
Not applicableEnded earlyNCT01938404
What this trial is testing

Octaplas Adult TTP Trial

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Octapharma 1
Not applicableLooking for participantsNCT02877706
What this trial is testing

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic Anemia
University Hospital, Toulouse 1,500
Large-scale testing (Phase 3)Study completedNCT00168038
What this trial is testing

Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10

Who this might be right for
Immune Thrombocytopenic Purpura
CSL Behring 58
Large-scale testing (Phase 3)Study completedNCT05621330
What this trial is testing

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 216
Not applicableNot Yet RecruitingNCT07724301
What this trial is testing

Regulation of Platelet Function in Older Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationThrombotic Risk
University of Michigan 50
Next Page